APA (7th ed.) Citation

Böhm, M., Butler, J., Filippatos, G., Ferreira, J. P., Pocock, S. J., Abdin, A., . . . Anker, S. D. (2022). Empagliflozin improves outcomes in patients with heart failure and preserved ejection fraction irrespective of age. Journal of the American College of Cardiology, 80(1), . https://doi.org/10.1016/j.jacc.2022.04.040

Chicago Style (17th ed.) Citation

Böhm, Michael, et al. "Empagliflozin Improves Outcomes In patients with Heart failure and Preserved Ejection Fraction Irrespective of Age." Journal of the American College of Cardiology 80, no. 1 (2022). https://doi.org/10.1016/j.jacc.2022.04.040.

MLA (9th ed.) Citation

Böhm, Michael, et al. "Empagliflozin Improves Outcomes In patients with Heart failure and Preserved Ejection Fraction Irrespective of Age." Journal of the American College of Cardiology, vol. 80, no. 1, 2022, https://doi.org/10.1016/j.jacc.2022.04.040.